Top Healthcare Stocks by Revenue
Top healthcare companies ranked by revenue, latest annual filings.
What Revenue Means for Healthcare Companies
Revenue is the top line of the income statement, the dollars booked from prescription drugs, medical devices, hospital services, insurance premiums, or diagnostic tests before any cost is deducted. In healthcare, the figure is shaped by payer mix, reimbursement rates, and regulatory exclusivity windows, so two firms with similar top lines can face very different durability depending on patent cliffs, payer concentration, and approval timing.
Why It Matters in Healthcare
Healthcare revenue signals the scale of a company's commercial franchise, the reach of its sales force, and, for drug and device makers, the strength of its approved portfolio. Large recurring revenue often funds the pipeline that replaces it. Still, revenue concentrated in one asset or one payer can mask fragility, since patent expirations, pricing reforms, or formulary changes can reshape the top line faster than costs can be cut.
What to Read Alongside
Pair revenue with Gross Margin to see pricing power net of the cost of therapy, R&D Spending for pipeline reinvestment intensity that replaces maturing franchises, and Free Cash Flow to confirm that reported revenue converts into actual cash.
| # | Symbol | Company | Sector | ||
|---|---|---|---|---|---|
| 1 | UNH | UnitedHealth Group Incorporated | Healthcare | $447.57B | $338.90B |
| 2 | MCK | McKesson Corporation | Healthcare | $403.43B | $103.35B |
| 3 | CVS | CVS Health Corporation | Healthcare | $402.07B | $112.04B |
| 4 | COR | Cencora, Inc. | Healthcare | $321.33B | $60.39B |
| 5 | CI | The Cigna Group | Healthcare | $274.90B | $72.53B |
| 6 | CAH | Cardinal Health, Inc. | Healthcare | $254.25B | $52.50B |
| 7 | ELV | Elevance Health, Inc. | Healthcare | $199.13B | $88.77B |
| 8 | CNC | Centene Corporation | Healthcare | $194.78B | $32.10B |
| 9 | HUM | Humana Inc. | Healthcare | $129.66B | $46.38B |
| 10 | JNJ | Johnson & Johnson | Healthcare | $94.19B | $649.40B |
| 11 | HCA | HCA Healthcare, Inc. | Healthcare | $75.60B | $92.22B |
| 12 | LLY | Eli Lilly and Company | Healthcare | $65.18B | $1038.33B |
| 13 | MRK | Merck & Co., Inc. | Healthcare | $65.01B | $368.84B |
| 14 | PFE | Pfizer Inc. | Healthcare | $62.58B | $158.11B |
| 15 | ABBV | AbbVie Inc. | Healthcare | $61.16B | $466.55B |
| 16 | AZN | AstraZeneca PLC | Healthcare | $58.74B | $260.71B |
| 17 | BMY | Bristol-Myers Squibb Company | Healthcare | $48.19B | $127.91B |
| 18 | MOH | Molina Healthcare, Inc. | Healthcare | $45.43B | $10.33B |
| 19 | TMO | Thermo Fisher Scientific Inc. | Healthcare | $44.56B | $243.57B |
| 20 | ABT | Abbott Laboratories | Healthcare | $44.33B | $178.19B |
| 21 | AMGN | Amgen Inc. | Healthcare | $36.75B | $212.55B |
| 22 | MDT | Medtronic plc | Healthcare | $36.36B | $117.36B |
| 23 | GILD | Gilead Sciences, Inc. | Healthcare | $29.44B | $186.69B |
| 24 | MDLN | Medline Inc. | Healthcare | $28.43B | $28.04B |
| 25 | SYK | Stryker Corporation | Healthcare | $25.12B | $105.17B |
| 26 | DHR | Danaher Corporation | Healthcare | $24.57B | $149.38B |
| 27 | BDX | Becton, Dickinson and Company | Healthcare | $21.84B | $49.22B |
| 28 | THC | Tenet Healthcare Corporation | Healthcare | $21.31B | $21.01B |
| 29 | GEHC | GE HealthCare Technologies Inc. | Healthcare | $20.63B | $29.27B |
| 30 | BSX | Boston Scientific Corporation | Healthcare | $20.07B | $63.36B |
| 31 | UHS | Universal Health Services, Inc. | Healthcare | $17.36B | $10.30B |
| 32 | TEVA | Teva Pharmaceutical Industries Limited | Healthcare | $17.26B | $46.72B |
| 33 | IQV | IQVIA Holdings Inc. | Healthcare | $16.31B | $44.42B |
| 34 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | $14.34B | $82.18B |
| 35 | VTRS | Viatris Inc. | Healthcare | $14.30B | $19.64B |
| 36 | LH | Labcorp Holdings Inc. | Healthcare | $13.95B | $26.03B |
| 37 | DVA | DaVita Inc. | Healthcare | $13.64B | $11.63B |
| 38 | HSIC | Henry Schein, Inc. | Healthcare | $13.18B | $9.50B |
| 39 | BTSG | BrightSpring Health Services, Inc. | Healthcare | $12.91B | $11.05B |
| 40 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | $12.00B | $129.45B |
| 41 | OSCR | Oscar Health, Inc. | Healthcare | $11.70B | $9.66B |
| 42 | BAX | Baxter International Inc. | Healthcare | $11.24B | $11.85B |
| 43 | DGX | Quest Diagnostics Incorporated | Healthcare | $11.04B | $27.03B |
| 44 | BHC | Bausch Health Companies Inc. | Healthcare | $10.27B | $2.11B |
| 45 | ISRG | Intuitive Surgical, Inc. | Healthcare | $10.06B | $141.89B |
| 46 | BIIB | Biogen Inc. | Healthcare | $9.89B | $32.37B |
| 47 | ZTS | Zoetis Inc. | Healthcare | $9.47B | $29.48B |
| 48 | SOLV | Solventum Corporation | Healthcare | $8.32B | $15.12B |
| 49 | ICLR | ICON Public Limited Company | Healthcare | $8.25B | $13.08B |
| 50 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | $8.23B | $17.99B |
| 51 | A | Agilent Technologies, Inc. | Healthcare | $6.95B | $45.66B |
| 52 | AVTR | Avantor, Inc. | Healthcare | $6.55B | $10.21B |
| 53 | ARDT | Ardent Health, Inc. | Healthcare | $6.32B | $1.50B |
| 54 | OGN | Organon & Co. | Healthcare | $6.22B | $3.59B |
| 55 | SNN | Smith & Nephew plc | Healthcare | $6.16B | $11.59B |
| 56 | EW | Edwards Lifesciences Corporation | Healthcare | $6.07B | $50.92B |
| 57 | STE | STERIS plc | Healthcare | $5.94B | $20.18B |
| 58 | EHC | Encompass Health Corporation | Healthcare | $5.94B | $11.99B |
| 59 | AGL | agilon health, inc. | Healthcare | $5.93B | $1.48B |
| 60 | RMD | ResMed Inc. | Healthcare | $5.65B | $32.26B |
| 61 | OPCH | Option Care Health, Inc. | Healthcare | $5.65B | $3.59B |
| 62 | SEM | Select Medical Holdings Corp | Healthcare | $5.45B | $2.05B |
| 63 | ONC | BeOne Medicines AG | Healthcare | $5.34B | $41.37B |
| 64 | PACS | PACS Group, Inc. | Healthcare | $5.29B | $6.66B |
| 65 | INCY | Incyte Corporation | Healthcare | $5.14B | $25.27B |
| 66 | BLCO | Bausch + Lomb Corporation | Healthcare | $5.10B | $6.00B |
| 67 | ENSG | The Ensign Group, Inc. | Healthcare | $5.06B | $10.17B |
| 68 | ELAN | Elanco Animal Health Incorporated | Healthcare | $4.71B | $11.21B |
| 69 | DXCM | DexCom, Inc. | Healthcare | $4.66B | $33.65B |
| 70 | ILMN | Illumina, Inc. | Healthcare | $4.34B | $36.06B |
| 71 | IDXX | IDEXX Laboratories, Inc. | Healthcare | $4.30B | $40.60B |
| 72 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | $4.27B | $15.67B |
| 73 | PRGO | Perrigo Company plc | Healthcare | $4.25B | $1.96B |
| 74 | ARGX | argenx SE | Healthcare | $4.25B | $61.82B |
| 75 | HOLX | Hologic, Inc. | Healthcare | $4.10B | $16.97B |
| 76 | COO | The Cooper Companies, Inc. | Healthcare | $4.09B | $10.29B |
| 77 | ALGN | Align Technology, Inc. | Healthcare | $4.03B | $10.43B |
| 78 | MTD | Mettler-Toledo International Inc. | Healthcare | $4.03B | $28.66B |
| 79 | CRL | Charles River Laboratories International, Inc. | Healthcare | $4.02B | $13.32B |
| 80 | ALHC | Alignment Healthcare, Inc. | Healthcare | $3.95B | $1.73B |
| 81 | ATR | AptarGroup, Inc. | Healthcare | $3.78B | $7.85B |
| 82 | GMAB | Genmab A/S | Healthcare | $3.72B | $21.33B |
| 83 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | $3.71B | $32.69B |
| 84 | XRAY | DENTSPLY SIRONA Inc. | Healthcare | $3.68B | $1.88B |
| 85 | RDY | Dr. Reddy's Laboratories Limited | Healthcare | $3.58B | $10.33B |
| 86 | BRKR | Bruker Corporation | Healthcare | $3.44B | $9.38B |
| 87 | ACHC | Acadia Healthcare Company, Inc. | Healthcare | $3.31B | $2.64B |
| 88 | SGRY | Surgery Partners, Inc. | Healthcare | $3.31B | $1.79B |
| 89 | EXAS | Exact Sciences Corp | Healthcare | $3.25B | $20.03B |
| 90 | AHCO | AdaptHealth Corp. | Healthcare | $3.24B | $0.77B |
| 91 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | $3.22B | $12.40B |
| 92 | VEEV | Veeva Systems Inc. | Healthcare | $3.20B | $42.31B |
| 93 | BKD | Brookdale Senior Living Inc. | Healthcare | $3.19B | $2.72B |
| 94 | UTHR | United Therapeutics Corporation | Healthcare | $3.18B | $21.15B |
| 95 | ASTH | Astrana Health, Inc. | Healthcare | $3.18B | $1.66B |
| 96 | WAT | Waters Corporation | Healthcare | $3.17B | $41.65B |
| 97 | MMED | MiniMed Group, Inc. | Healthcare | $3.10B | $5.94B |
| 98 | WST | West Pharmaceutical Services, Inc. | Healthcare | $3.07B | $25.46B |
| 99 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | $3.02B | $7.02B |
| 100 | GMED | Globus Medical, Inc. | Healthcare | $2.94B | $9.97B |
No companies match this search.
How this ranking is built
Companies are ranked by revenue as reported in their most recent annual filing with the SEC. Figures shown are in US dollars (or percent, as noted), rounded to two decimals.
- Source: annual 10-K / 20-F filings from companies trading on US exchanges (NYSE, Nasdaq, AMEX).
- Fiscal year: whichever annual period the company has most recently filed. Fiscal years don't always align with the calendar year, so the "as of FY" stamp above reflects the most common year across the table.
- Filtered out: warrants, preferred shares, and duplicate listings that share a parent company's financials.
- Size floor: A company qualifies at $500 million in market cap or above. Below that, one mis-stated figure outranks the companies the list is about.
- Currency check: A company whose annual revenue runs above 15 times its market cap is left out, because at that gap the two figures are not in the same currency.
- Currency check: A company whose balance sheet runs above 150 times its market cap is left out for the same reason.
- Update cadence: refreshed as companies file new annual reports (typically within 60–90 days of fiscal year end).
Not financial advice. This is a research tool, not a recommendation.